What Happens to the Skin During Rapid, Medication-Assisted Weight Loss?

With the rise of GLP-1 therapies, many professionals are now seeing a new pattern in the treatment room:

  • Sudden loss of facial volume

  • Accelerated skin laxity

  • Early fine lines and crepey texture

  • Changes that are structural, not inflammatory

This isn’t simply “cosmetic aging.”
It’s a physiologic consequence of rapid fat loss, muscle changes, and altered cellular metabolism.

A few months ago, we explored this in depth in our blog on skin laxity, muscle loss, and NADâș support, and how cellular energy pathways may influence how the skin adapts during major metabolic change.

If you’re treating clients on GLP-1 therapies, this is an important read for understanding:

  • Why laxity appears so quickly

  • The role of muscle and fibroblast energy

  • And how cellular-support strategies may help maintain skin integrity

👉 Read the full blog here: #GLP-1 & Skin Laxity: What You Need to Know and How to Support the Skin with Pro NAD